Ophthalmology Doctors in Marshfield, WI Accepting Medicare

9 Ophthalmology doctors found. Showing 1 - 9

Asha Yancy Okorie, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

Dr. Giancarlo Amado Garcia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

Scott J Paulman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-7574

James A Holzberger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-7572

Richard B Patchett, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 713-387-9371

Maryam I. Najjar, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 866-520-2510

Rebecca M Bartow, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-7575

John P Mitchell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511

Dennis R Anderson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-389-4027

News Archive

New book sheds light on addiction to psychoactive drugs

Cold Spring Harbor Laboratory Press (CSHLP) announced the publication of Addiction, 2e, now available on its website in ebook and hardcover formats.

Shame and blame stops women leaving violent men

Researchers in New Zealand say shame and self-blame often stop women leaving violent relationships and campaigns advocating choice and empowerment aimed at prompting abused women to leave their abusers may in some cases have the opposite effect.

Momenta prices underwritten public offering

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.

Adult children of mothers with Alzheimer's at increased risk

A family history of Alzheimer's disease significantly increases the risk for developing this disorder, but a new study in Biological Psychiatry suggests that which of your parents has the disease is very important.

Read more Medical News

› Verified 9 days ago